Revision history of "Development of biotechnology direction at the Latvian Institute of Organic Synthesis to achieve excellence in the field of drug detection (BioDrug)" (Q3056546)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

12 March 2024

12 June 2023

17 August 2022

  • curprev 12:3612:36, 17 August 2022DG Regio talk contribs 96,418 bytes +62,732 Changed label, description and/or aliases in el, da, fi, mt, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl, nl, fr, de, it, lv, es, and other parts: Adding translations: el, da, fi, mt, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl,

12 January 2022

11 January 2022

28 November 2021

  • curprev 18:0218:02, 28 November 2021DG Regio talk contribs 25,672 bytes +3,562 Created claim: summary (P836): De aanvraag voor het project „Biotechnology at Latvian Institute of Organic Synthesis to achieve excellence in Drug Discovery (BIODRUG)” (aanvraagnummer 857290) is ingediend bij de Horizon 2020 Spreading Excellence and Widening Participation Subprogramma ERA-leerstoelen en voldoet derhalve aan het subprogramma „Verspreiding van topkwaliteit en verbreding van deelname” van het Horizon 2020-programma voor topkwaliteit en verbreding van deelname, z...
  • curprev 18:0218:02, 28 November 2021DG Regio talk contribs 22,110 bytes +220 Changed label, description and/or aliases in nl: translated_label
  • curprev 09:2609:26, 28 November 2021DG Regio talk contribs 21,890 bytes +3,771 Created claim: summary (P836): Der Antrag für das Projekt „Biotechnologie am lettischen Institut für organische Synthese zur Erreichung von Exzellenz in der Arzneimittelforschung (BIODRUG)“ (Antragsnummer 857290) wurde beim Teilprogramm ERA-Lehrstühle von Horizont 2020 zur Verbreitung von Exzellenz und breiterer Beteiligung eingereicht und entspricht somit dem Teilprogramm „Verbreitung von Exzellenz und breitere Beteiligung“ des Exzellenzprogramms Horizont 2020 und der Auswei...
  • curprev 09:2609:26, 28 November 2021DG Regio talk contribs 18,119 bytes +207 Changed label, description and/or aliases in de: translated_label

25 November 2021

  • curprev 19:3519:35, 25 November 2021DG Regio talk contribs 17,912 bytes +3,634 Created claim: summary (P836): La demande pour le projet «Biotechnologie à l’Institut letton de synthèse biologique pour atteindre l’excellence en matière de découverte de médicaments (BIODRUG)» (numéro de demande 857290) a été soumise au sous-programme «Excellence et participation élargie» d’Horizon 2020 et est donc conforme au sous-programme «Diffusion de l’excellence et participation élargie» du programme d’excellence et de participation élargie d’Horizon 2020, tel qu’énon...
  • curprev 19:3519:35, 25 November 2021DG Regio talk contribs 14,278 bytes +238 Changed label, description and/or aliases in fr: translated_label

27 September 2021

10 September 2021

15 July 2021

  • curprev 12:3612:36, 15 July 2021DG Regio talk contribs 13,620 bytes +207 Changed label, description and/or aliases in en: translated_label
  • curprev 12:3612:36, 15 July 2021DG Regio talk contribs 13,413 bytes +3,034 Created claim: summary (P836): The application for “Biotechnology at Latvian Institute of Organic Synthesis to achieve excellence in drug discovery (BIODRUG)” (application number 857290) was submitted to the “Horizon 2020” Spreading Excellence and Widening Participation sub-programme ERA Chairs and thus complies with the Sub-programme for Distribution of Excellence and Widening Participation set out in point 53.1 of the MC. Its implementation will facilitate the development o...

14 July 2021

13 July 2021